CSTL Castle Biosciences PE ratio, current and historical analysis
The PE ratio for Castle Biosciences stock stands at 28.42 as of Mar 13, 2025. The calculation is based on the latest EPS of $0.66 and the stock price of $18.76 per share.
CSTL PE ratio history
Castle Biosciences PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 40.38 | N/A | $26.65 | $0.66 |
| 2023 | N/A | N/A | $21.58 | -$2.14 |
| 2022 | N/A | N/A | $23.54 | -$2.58 |
| 2021 | N/A | N/A | $42.87 | -$1.24 |
| 2020 | N/A | N/A | $67.15 | -$0.54 |
| 2019 | 98.2 | N/A | $34.37 | $0.35 |
| 2018 | N/A | N/A | N/A | -$5.33 |
| 2017 | N/A | N/A | N/A | -$8.08 |
Castle Biosciences PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 40.38 | -68.85% | $26.65 | $0.66 |
| Sep 2024 | 129.64 | N/A | $28.52 | $0.22 |
| Jun 2024 | N/A | N/A | $21.77 | -$0.12 |
| Mar 2024 | N/A | N/A | $22.15 | -$1.14 |
| Dec 2023 | N/A | N/A | $21.58 | -$2.14 |
| Sep 2023 | N/A | N/A | $16.89 | -$2.85 |
| Jun 2023 | N/A | N/A | $13.72 | -$3.36 |
| Mar 2023 | N/A | N/A | $22.72 | -$2.72 |
| Dec 2022 | N/A | N/A | $23.54 | -$2.58 |
| Sep 2022 | N/A | N/A | $26.08 | -$2.05 |
| Jun 2022 | N/A | N/A | $21.95 | -$1.75 |
| Mar 2022 | N/A | N/A | $44.86 | -$2.04 |
| Dec 2021 | N/A | N/A | $42.87 | -$1.24 |
| Sep 2021 | N/A | N/A | $66.5 | -$1.24 |
| Jun 2021 | N/A | N/A | $73.33 | -$1 |
CSTL average PE ratio chart
CSTL PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| CSTL Castle Biosciences Inc | 28.42 | $534.92M |
| OPTN OptiNose Inc | N/A | $54M |
| OPK Opko Health Inc | N/A | $1.16B |
| ORGO Organogenesis Holdings Inc | N/A | $665.85M |
Frequently asked questions
What is Castle Biosciences's PE ratio?
CSTL's price to earnings ratio is 28.42 as of Mar 13, 2025.
How is CSTL's PE ratio calculated (Castle Biosciences PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Mar 13, 2025), Castle Biosciences's share price is $18.76. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.66. Therefore, Castle Biosciences's PE ratio for today is 28.42. PE RATIO(28.42) = STOCK PRICE($18.76) / TTM EPS($0.66)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.